Hylasco Bio-Technology (India) Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 27.31 Cr
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth 36.85%
- Profit Growth 82.83%
- Ebitda 22.63%
- Net Worth 29.51%
- Total Assets 27.30%
About Hylasco Bio-Technology (India)
Hylasco Bio-Technology (India) Private Limited (HBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 May 2012 and has a history of 12 years and eight months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 27.31 Cr.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hylasco Bio-Technology (India) Private Limited India is Ravina Sood as COMPANY SECRETARY. Richard Lee, Jae Chang, Cheng Chung, and One other member serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U01409TG2012PTC080696
- Company No.
080696
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hylasco Bio-Technology (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravina Sood  | Company Secretary | 03-Jun-2019 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jae Chang  | Director | 23-Feb-2017 | Current |
Richard Lee  | Director | 03-May-2012 | Current |
Cheng Chung  | Nominee Director | 21-Sep-2017 | Current |
| Khaleel Mohammad | Director | 26-Mar-2024 | Current |
Financial Performance of Hylasco Bio-Technology (India).
Hylasco Bio-Technology (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.85% increase. The company also saw a substantial improvement in profitability, with a 82.83% increase in profit. The company's net worth Soared by an impressive increase of 29.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hylasco Bio-Technology (India)?
In 2023, Hylasco Bio-Technology (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.50 Cr
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 1.00 Cr
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2018 | Others | ₹5.00 M | Satisfied |
| 31 Mar 2015 | Bank Of Baroda | ₹1.00 Cr | Satisfied |
How Many Employees Work at Hylasco Bio-Technology (India)?
Unlock and access historical data on people associated with Hylasco Bio-Technology (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hylasco Bio-Technology (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hylasco Bio-Technology (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
